Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,481,032
-
Share change
-
-132,394
-
Total reported value
-
$61,896,317
-
Price per share
-
$4.01
-
Number of holders
-
35
-
Value change
-
-$1,259,160
-
Number of buys
-
14
-
Number of sells
-
14
Institutional Holders of CONSTELLATION PHARMCETICLS I - COM (CNST) as of Q4 2018
As of 31 Dec 2018,
CONSTELLATION PHARMCETICLS I - COM (CNST) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,481,032 shares.
The largest 10 holders included
Svennilson Peter, TRV GP, LLC, FMR LLC, Casdin Capital, LLC, Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, VHCP Management II, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Hillhouse Capital Management, Ltd., and BAKER BROS. ADVISORS LP.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.